L-Arginine inhibits xanthine oxidase-dependent endothelial dysfunction in hypercholesterolemia

FEBS Lett. 2004 Mar 12;561(1-3):94-8. doi: 10.1016/S0014-5793(04)00137-1.

Abstract

Xanthine oxidase (XO)-derived superoxide contributes to endothelial dysfunction in humans and animal models of hypercholesterolemia (HC). Since L-arginine supplementation prevents defects in NO signaling, we tested the hypothesis that L-arginine blunts the inhibitory effect of XO on vascular function. Acetylcholine-mediated relaxation was significantly impaired in ring segments of HC rabbits, a response that was associated with an increase in plasma XO activity. L-Arginine treatment of HC rabbits reduced plasma XO and improved endothelial function. L-Arginine also modestly prolonged the lag time for oxidation in isolated lipoprotein samples. These results reveal that the principal action of L-arginine is to protect against the XO-dependent inactivation of NO in arteries of HC rabbits.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Aorta / physiology
  • Arginine / administration & dosage
  • Arginine / pharmacology*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiopathology
  • Hypercholesterolemia / drug therapy
  • Hypercholesterolemia / physiopathology*
  • Nitric Oxide / metabolism
  • Rabbits
  • Vasodilation / drug effects
  • Xanthine Oxidase / blood
  • Xanthine Oxidase / drug effects*

Substances

  • Nitric Oxide
  • Arginine
  • Xanthine Oxidase
  • Acetylcholine